Complement activation as a biomarker for Alzheimer's disease

MLA

Aiyaz, Mohammed, et al. “Complement Activation as a Biomarker for Alzheimer’s Disease.” Immunobiology, vol. 217, no. 2, Feb. 2012, pp. 204–15. EBSCOhost, https://doi.org/10.1016/j.imbio.2011.07.023.

APA

Aiyaz, M., Lupton, M. K., Proitsi, P., Powell, J. F., & Lovestone, S. (2012). Complement activation as a biomarker for Alzheimer’s disease. Immunobiology, 217(2), 204–215. https://doi.org/10.1016/j.imbio.2011.07.023

Chicago

Aiyaz, Mohammed, Michelle K. Lupton, Petroula Proitsi, John F. Powell, and Simon Lovestone. 2012. “Complement Activation as a Biomarker for Alzheimer’s Disease.” Immunobiology 217 (2): 204–15. doi:10.1016/j.imbio.2011.07.023.